Angiogenesis in the Normal Adrenal Fetal Cortex and Adrenocortical Tumors
- PMID: 33804534
- PMCID: PMC7957756
- DOI: 10.3390/cancers13051030
Angiogenesis in the Normal Adrenal Fetal Cortex and Adrenocortical Tumors
Abstract
Angiogenesis plays an important role in several physiological and pathological processes. Pharmacological angiogenesis modulation has been robustly demonstrated to achieve clinical benefits in several cancers. Adrenocortical carcinomas (ACC) are rare tumors that often have a poor prognosis. In addition, therapeutic options for ACC are limited. Understanding the mechanisms that regulate adrenocortical angiogenesis along the embryonic development and in ACC could provide important clues on how these processes could be pharmacologically modulated for ACC treatment. In this report, we performed an integrative review on adrenal cortex angiogenesis regulation in physiological conditions and ACC. During embryonic development, adrenal angiogenesis is regulated by both VEGF and Ang-Tie signaling pathways. In ACC, early research efforts were focused on VEGF signaling and this pathway was identified as a good prognostic factor and thus a promising therapeutic target. However, every clinical trial so far conducted in ACC using VEGF pathway- targeting drugs, alone or in combination, yielded disappointing results. In contrast, although the Ang-Tie pathway has been pointed out as an important regulator of fetal adrenocortical angiogenesis, its role is yet to be explored in ACC. In the future, further research on the role and efficacy of modulating both Ang-Tie and VEGF pathways in ACC is needed.
Keywords: adrenal fetal cortex; adrenocortical carcinoma; adrenocortical tumors; angiogenesis; anti-angiogenic drugs.
Conflict of interest statement
The authors declare no conflict of interest.
Figures

Similar articles
-
Ang-Tie Angiogenic Pathway Is Distinctively Expressed in Benign and Malignant Adrenocortical Tumors.Int J Mol Sci. 2022 May 17;23(10):5579. doi: 10.3390/ijms23105579. Int J Mol Sci. 2022. PMID: 35628389 Free PMC article.
-
An Interesting Case of Hepatic Adrenocortical Carcinoma.Acta Med Indones. 2018 Jul;50(3):257-259. Acta Med Indones. 2018. PMID: 30333277
-
Past, Present and Future of Epigenetics in Adrenocortical Carcinoma.Cancers (Basel). 2020 May 13;12(5):1218. doi: 10.3390/cancers12051218. Cancers (Basel). 2020. PMID: 32414074 Free PMC article. Review.
-
Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors.Horm Cancer. 2015 Dec;6(5-6):225-36. doi: 10.1007/s12672-015-0236-z. Horm Cancer. 2015. PMID: 26475302 Free PMC article.
-
Angiopoietins in angiogenesis.Cancer Lett. 2013 Jan 1;328(1):18-26. doi: 10.1016/j.canlet.2012.08.018. Epub 2012 Aug 23. Cancer Lett. 2013. PMID: 22922303 Review.
Cited by
-
The Impact of Fetal Growth Restriction on Prenatal 2D Ultrasound and Doppler Study of the Fetal Adrenal Gland.J Pregnancy. 2024 Aug 29;2024:9968509. doi: 10.1155/2024/9968509. eCollection 2024. J Pregnancy. 2024. PMID: 39238897 Free PMC article.
-
The Characteristics of Tumor Microenvironment Predict Survival and Response to Immunotherapy in Adrenocortical Carcinomas.Cells. 2023 Feb 27;12(5):755. doi: 10.3390/cells12050755. Cells. 2023. PMID: 36899891 Free PMC article.
-
An integrated single-cell analysis of human adrenal cortex development.JCI Insight. 2023 Jul 24;8(14):e168177. doi: 10.1172/jci.insight.168177. JCI Insight. 2023. PMID: 37440461 Free PMC article.
-
Vascular and hormonal interactions in the adrenal gland.Front Endocrinol (Lausanne). 2022 Nov 24;13:995228. doi: 10.3389/fendo.2022.995228. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36506065 Free PMC article. Review.
-
Ang-Tie Angiogenic Pathway Is Distinctively Expressed in Benign and Malignant Adrenocortical Tumors.Int J Mol Sci. 2022 May 17;23(10):5579. doi: 10.3390/ijms23105579. Int J Mol Sci. 2022. PMID: 35628389 Free PMC article.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous